Overview
Katiane Tostes practices practicing medicine in Campinas, Brazil.
Their clinical expertise encompasses Secondary Parkinsonism, Non-Small Cell Lung Cancer (NSCLC), Neurotoxicity Syndromes, and Lung Cancer.
They are actively involved in clinical research, co-authoring 13 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Katiane Tostes
Is Katiane Tostes a top-rated expert for Secondary Parkinsonism?
MediFind is an objective health platform that identifies experts based on real-world data. Katiane Tostes is classified as an Experienced expert for Secondary Parkinsonism, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Katiane Tostes participate in research or clinical trials?
Yes. Katiane Tostes has published 13 articles and abstracts on conditions like Secondary Parkinsonism. You can view a list of Katiane Tostes's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung CancerTostes isExperienced. Learn about Lung Cancer.
- Neurotoxicity SyndromesTostes isExperienced. Learn about Neurotoxicity Syndromes.
- Non-Small Cell Lung Cancer (NSCLC)
- Secondary ParkinsonismTostes isExperienced. Learn about Secondary Parkinsonism.